par Vanlander, Arnaud Vincent;Smet, Joel;De Paepe, Boel;De Latter, Elien;Van Coster, Rudy;Menten, Björn;Sante, Tom;Vergult, Sarah;Vantomme, Lies;De Meirleir, Linda;Seneca, Sara;Pearce, Sarah S.F.;Powell, Christopher C.A.;Minczuk, Michal;Michotte, Alex
Référence Human mutation, 36, 2, page (222-231)
Publication Publié, 2015-02
Référence Human mutation, 36, 2, page (222-231)
Publication Publié, 2015-02
Article révisé par les pairs
Résumé : | A homozygous missense mutation (c.822G>C) was found in the gene encoding the mitochondrial asparaginyl-tRNA synthetase (NARS2) in two siblings born to consanguineous parents. These siblings presented with different phenotypes: one had mild intellectual disability and epilepsy in childhood, whereas the other had severe myopathy. Biochemical analysis of the oxidative phosphorylation (OXPHOS) complexes in both siblings revealed a combined complex I and IV deficiency in skeletal muscle. In-gel activity staining after blue native-polyacrylamide gel electrophoresis confirmed the decreased activity of complex I and IV, and, in addition, showed the presence of complex V subcomplexes. Considering the consanguineous descent, homozygosity mapping and whole-exome sequencing were combined revealing the presence of one single missense mutation in the shared homozygous region. The c.822G>C variant affects the 3′ splice site of exon 7, leading to skipping of the whole exon 7 and a part of exon 8 in the NARS2 mRNA. In EBV-transformed lymphoblasts, a specific decrease in the amount of charged mt-tRNAAsn was demonstrated as compared with controls. This confirmed the pathogenic nature of the variant. To conclude, the reported variant in NARS2 results in a combined OXPHOS complex deficiency involving complex I and IV, making NARS2 a new member of disease-associated aaRS2. |